| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.03 |